Literature DB >> 9806831

Identification of mammaglobin B, a novel member of the uteroglobin gene family.

R M Becker1, C Darrow, D B Zimonjic, N C Popescu, M A Watson, T P Fleming.   

Abstract

In this report, we have identified, sequenced, and characterized the expression pattern of a novel human gene, mammaglobin B. Mammaglobin B (MGB2) is highly homologous to mammaglobin (MGB1), a previously characterized human gene whose expression is limited to the mammary epithelium and frequently up-regulated in human breast cancer cells. Based upon amino acid sequence similarities, both mammaglobin and mammaglobin B may be considered members of a larger, mammalian multigene family that includes rabbit uteroglobin, human Clara Cell 10-kDa protein (CC10), and the multimeric rat prostatein protein. Together with the human CC10 gene, mammaglobin and mammaglobin B are closely linked on human chromosome 11q13. However, despite their primary sequence similarity and close chromosomal proximity, the expression of mammaglobin and mammaglobin B is nonconcordant in both nonmalignant and neoplastic tissue. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806831     DOI: 10.1006/geno.1998.5539

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues.

Authors:  Mechthild Stoeckelhuber; Elisabeth M Messmer; Corina Schmidt; Fei Xiao; Christoph Schubert; Jörg Klug
Journal:  Histochem Cell Biol       Date:  2006-01-04       Impact factor: 4.304

2.  Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study.

Authors:  V Luyckx; J F Durant; A Camboni; S Gilliaux; C A Amorim; A Van Langendonckt; L M Irenge; J L Gala; J Donnez; M M Dolmans
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

3.  Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate.

Authors:  Rebecca Lee Yean Wong; Quan Wang; Lindsey S Treviño; Maarten C Bosland; Jing Chen; Mario Medvedovic; Gail S Prins; Kurunthachalam Kannan; Shuk-Mei Ho; Cheryl Lyn Walker
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Evaluation of lipophilins as determinants of tumor cell response to estramustine.

Authors:  Jody M Tucker; Zhanna Lipatova; Vladimir Beljanski; Danyelle M Townsend; Kenneth D Tew
Journal:  J Pharmacol Exp Ther       Date:  2005-08-24       Impact factor: 4.030

5.  Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.

Authors:  Menelaos Zafrakas; Beate Petschke; Andreas Donner; Florian Fritzsche; Glen Kristiansen; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2006-04-09       Impact factor: 4.430

6.  Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Authors:  S Bellone; R Tassi; M Betti; D English; E Cocco; S Gasparrini; I Bortolomai; J D Black; P Todeschini; C Romani; A Ravaggi; E Bignotti; E Bandiera; L Zanotti; S Pecorelli; L Ardighieri; M Falchetti; C Donzelli; E R Siegel; M Azodi; D-A Silasi; E Ratner; P E Schwartz; T J Rutherford; A D Santin
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

7.  Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

Authors:  Renata A Tassi; Stefano Calza; Antonella Ravaggi; Eliana Bignotti; Franco E Odicino; Germana Tognon; Carla Donzelli; Marcella Falchetti; Elisa Rossi; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Sergio Pecorelli; Alessandro D Santin
Journal:  BMC Cancer       Date:  2009-07-27       Impact factor: 4.430

8.  Mammaglobin as a potential molecular target for breast cancer drug delivery.

Authors:  Lian Zuo; Ly Li; Qian Wang; Timothy P Fleming; Shaojin You
Journal:  Cancer Cell Int       Date:  2009-03-23       Impact factor: 5.722

9.  Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.

Authors:  A Nissan; D Jager; M Roystacher; D Prus; T Peretz; I Eisenberg; H R Freund; M Scanlan; G Ritter; L J Old; S Mitrani-Rosenbaum
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

Authors:  Eliana Bignotti; Renata A Tassi; Stefano Calza; Antonella Ravaggi; Elisa Rossi; Carla Donzelli; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Mario Carnazza; Francesco Quadraro; Germana Tognon; Enrico Sartori; Sergio Pecorelli; Dana M Roque; Alessandro D Santin
Journal:  J Transl Med       Date:  2013-07-02       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.